Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell surface receptors and adhesion sites represent a broad category of molecular structures essential for maintaining the gastrointestinal barrier and mediating interactions between the host and the luminal environment. These include pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) that sense microbial signals, nutrient transporters, and specialized adhesion complexes such as tight junctions (claudins, occludin), adherens junctions (E-cadherin), and desmosomes (NIH, 2023, 'Intestinal Epithelial Barrier'). These structures regulate paracellular permeability and coordinate the innate immune response within the gut mucosa (Nature Reviews Gastroenterology & Hepatology, 2021, 'The intestinal epithelial barrier: a therapeutic target?'). Dysfunction of these receptors and adhesion sites is a primary driver of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, as well as celiac disease and various enteric infections (PubMed, 2022, 'Epithelial Barrier Function in Health and Disease'). Therapeutic interventions often target specific components within this category, such as integrins to prevent leukocyte infiltration or junctional proteins to restore barrier integrity. Because this term encompasses a wide variety of distinct proteins and structural complexes rather than a single molecular entity, it is classified as a biological system or category rather than a specific therapeutic target (StatPearls, 2023, 'Physiology, Gastrointestinal Barrier').
Modulation of paracellular permeability, inhibition of leukocyte trafficking to the gut mucosa, and stabilization of the epithelial junctional complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell surface receptors and adhesion sites.